Assessment of cognitive function using the Montreal cognitive assessment test and its association with glycemic control in diabetes mellitus patients

Sakthi Saranya K; Shanthimalar Ramamoorthy; Vijayalakshmi T N; Sathya Palaniswamy

doi:10.5455/njppp.2023.13.09459202315102023

2026, Vol: 16, Issue: 2

16 / 2Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

NJPPP Manuscript Submission Form
Title Page

« Previous Article

Original Research
Online Published: 28 Oct 2023

Natl J Physiol Pharm Pharmacol. 2024; 14(5): 900-904

doi: 10.5455/njppp.2023.13.09459202315102023

Assessment of cognitive function using the Montreal cognitive assessment test and its association with glycemic control in diabetes mellitus patients

Sakthi Saranya K, Shanthimalar Ramamoorthy, Vijayalakshmi T N, Sathya Palaniswamy.

Abstract
Background: Diabetes mellitus (DM) is associated with decreased performance on cognitive domains. Diabetic patients have poor memory and attention. Cognitive dysfunction has emerged as significant morbidity of DM nowadays. Cognitive function can be screened rapidly by Montreal cognitive assessment test (MoCA).

Aims and Objectives: The objective of this study was to study the effect of blood glucose levels and diabetic duration on MoCA score in diabetic patients.

Materials and Methods: DM patients of both type 1(30) and type 2(30) from NCD clinic were selected as cases. Thirty persons with good health from master health checkup were selected as controls. Cognitive function was assessed in all the participants with MoCA after getting informed consent. Fasting and postprandial blood sugars were assessed with 2 mL of venous blood.

Results: The mean MoCA score has decreased among diabetic cases than controls. Among cases, T1DM has decreased mean MoCA score than T2DM. Fasting blood sugar (FBS), post prandial blood sugar (PPBS), and diabetic duration were found to be correlated negatively with the score obtained in MoCA in controls and T1DM cases. In T2DM cases, FBS and PPBS were found to be correlated negatively with the score obtained in MoCA, but weak positive correlation was found between duration and MoCA score.

Conclusion: Our study concludes an association between FBS, PPBS, and duration of diabetes with MoCA score in diabetic patients of both types. Strict glycemic control and regular screening for cognitive dysfunction can prevent dementia.

Key words: Fasting Blood Sugar; Post Prandial Blood Sugar; Diabetes Mellitus; Montreal Cognitive Assessment Test; Mild Cognitive Impairment

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Sakthi Saranya K Articles by Shanthimalar Ramamoorthy Articles by Vijayalakshmi T N Articles by Sathya Palaniswamy
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

K SS, Ramamoorthy S, N VT, Palaniswamy S. Assessment of cognitive function using the Montreal cognitive assessment test and its association with glycemic control in diabetes mellitus patients. Natl J Physiol Pharm Pharmacol. 2024; 14(5): 900-904.

doi:10.5455/njppp.2023.13.09459202315102023

Web Style

K SS, Ramamoorthy S, N VT, Palaniswamy S. Assessment of cognitive function using the Montreal cognitive assessment test and its association with glycemic control in diabetes mellitus patients. https://www.njppp.com/?mno=170165 [Access: June 27, 2026].

doi:10.5455/njppp.2023.13.09459202315102023

AMA (American Medical Association) Style

K SS, Ramamoorthy S, N VT, Palaniswamy S. Assessment of cognitive function using the Montreal cognitive assessment test and its association with glycemic control in diabetes mellitus patients. Natl J Physiol Pharm Pharmacol. 2024; 14(5): 900-904.

doi:10.5455/njppp.2023.13.09459202315102023

Vancouver/ICMJE Style

K SS, Ramamoorthy S, N VT, Palaniswamy S. Assessment of cognitive function using the Montreal cognitive assessment test and its association with glycemic control in diabetes mellitus patients. Natl J Physiol Pharm Pharmacol. (2024), [cited June 27, 2026]; 14(5): 900-904.

doi:10.5455/njppp.2023.13.09459202315102023

Harvard Style

K, S. S., Ramamoorthy, . S., N, . V. T. & Palaniswamy, . S. (2024) Assessment of cognitive function using the Montreal cognitive assessment test and its association with glycemic control in diabetes mellitus patients. Natl J Physiol Pharm Pharmacol, 14 (5), 900-904.

doi:10.5455/njppp.2023.13.09459202315102023

Turabian Style

K, Sakthi Saranya, Shanthimalar Ramamoorthy, Vijayalakshmi T N, and Sathya Palaniswamy. 2024. Assessment of cognitive function using the Montreal cognitive assessment test and its association with glycemic control in diabetes mellitus patients. National Journal of Physiology, Pharmacy and Pharmacology, 14 (5), 900-904.

doi:10.5455/njppp.2023.13.09459202315102023

Chicago Style

K, Sakthi Saranya, Shanthimalar Ramamoorthy, Vijayalakshmi T N, and Sathya Palaniswamy. "Assessment of cognitive function using the Montreal cognitive assessment test and its association with glycemic control in diabetes mellitus patients." National Journal of Physiology, Pharmacy and Pharmacology 14 (2024), 900-904.

doi:10.5455/njppp.2023.13.09459202315102023

MLA (The Modern Language Association) Style

doi:10.5455/njppp.2023.13.09459202315102023

APA (American Psychological Association) Style

doi:10.5455/njppp.2023.13.09459202315102023

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article